|
Volumn 66, Issue 5, 2005, Pages 1110.e9-1110.e11
|
Abnormal fluorescence in situ hybridization analysis in collecting duct carcinoma
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CISPLATIN;
GEMCITABINE;
IFOSFAMIDE;
PACLITAXEL;
ADULT;
ARTICLE;
BIOPSY;
CANCER CHEMOTHERAPY;
CANCER DIAGNOSIS;
CANCER SURGERY;
CASE REPORT;
CYTOLOGY;
DRUG WITHDRAWAL;
FEMALE;
FLUORESCENCE IN SITU HYBRIDIZATION;
HUMAN;
KIDNEY CARCINOMA;
KIDNEY COLLECTING TUBULE CARCINOMA;
LYMPH NODE METASTASIS;
NEPHRECTOMY;
POSTOPERATIVE PERIOD;
PRIORITY JOURNAL;
TOXICITY;
TREATMENT OUTCOME;
UROGRAPHY;
|
EID: 27744479696
PISSN: 00904295
EISSN: 15279995
Source Type: Journal
DOI: 10.1016/j.urology.2005.06.074 Document Type: Article |
Times cited : (5)
|
References (9)
|